SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (OTCQB: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological ...
Spruce Biosciences (OTC:SPRB) will implement a 1-for-75 reverse stock split effective August 4, 2025. Post-split trading will begin on August 5, 2025, under the same ticker “SPRB”. The reverse split ...
Spruce Biosciences, Inc. (SPRB) has disclosed a new risk, in the Share Price & Shareholder Rights category. Spruce Biosciences, Inc. faces a significant risk as it navigates the threat of delisting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback